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1. The role of educational level in cognitive ability-diabetes association 
 
Educational level was coded in five categories, ranging from ‘no qualification’ to ‘degree’. 
Educational level was negatively associated with diabetes, such that each additional educational 
level incurred 26% lower odds of having self-reported diabetes (OR = 0.74, 95% CI: 0.60, 0.90) 
and 22% lower odds of having a HbA1C level above 6.5% (OR = 0.78, 95% CI: 0.66, 0.92). 
 
Next, we attempted to fit educational level in the life-course model of cognitive ability and diabetes. 
As has been discussed at length in an epidemiological setting, there are  arguments for 
considering educational level as both the outcome and contributor to cognitive ability, such that 
higher initial cognitive ability level contributes to obtaining better education, which, then, further 
contributes to cognitive ability [1]. As a result, and given the time-line of events, it is probably the 
best to consider age-11 cognitive ability as a causal contributor to both educational level and age-
70 cognitive ability, with the latter also being influenced by educational level. As for diabetes in 
older age, it is possible that it is linked to educational level (such as was described in the previous 
paragraph) but it also receives both direct and indirect (via educational level) contributions from 
childhood cognitive ability. The only real difficulty is related to the causality in the associations 
between older-age diabetes and cognitive ability: diabetes is typically considered to be causal to 
cognitive functioning but the findings of the present study (people with diabetes in older age had 
similarly lower cognitive ability already in childhood) seem to suggest the opposite. So, for the 
moment, it is probably best to remain agnostic about the causality in this association. 
 
We tested these multivariate associations by means of structural equation modelling as 
implemented in the Mplus 6 software [2]. The specified model, which is based on the reasoning 
above and treated self-reported diabetes as a categorical variable, is shown in the Figure S1 along 
with standardized model estimates. The model used weighted least squares means and variance 
adjusted (WLSMV) estimation. Due to unclear causality in the association between older-age 
diabetes and cognitive ability, we specified this association as a correlation. Also, although not 
shown in the model, all variables were residualized for sex, whereas diabetes and age-70 cognitive 
ability were also residualized for age at the older-age testing. The model fit data acceptably well: 
comparative fit index (CFI) = 1.00, root mean square error of approximation (RMSEA) = 0.064 
(90% confidence intervals: 0.019, 0.122). 
 
Figure S1 shows that, after considering the contributions from childhood cognitive ability, 
educational level, only the latter made an independent significant contribution to diabetes status. 
However, two things should be emphasized.  
 
First, educational level received a strong contribution from age-11 cognitive ability and, therefore, 
the latter was likely to indirectly (via education) contribute to diabetes status in older age. In other 
words, education was likely to mediate the childhood cognitive ability-older age diabetes 
association. A formal statistical test (in Mplus 6) confirmed this: the indirect effect of age-11 
cognitive ability to diabetes was β = -0.07 (p = 0.02). As a result, the total effect was β = -0.08 + (-
0.07) = -0.15 and it was statistically significant (p = 0.007). 
 
 
 
Figur
e S1. 
Multi
varia
te 
asso
ciati
ons 
betw
een cognitive ability, educational level and diabetes as tested using structural equation 
modelling. The estimates are standardized coefficients. * p < 0.05; *** p < 0.001; ns = non-
significant. 
 
 
Second, in this multivariate model the association between age-70 cognitive ability and diabetes 
was close to zero, suggesting little causal role of diabetes on cognitive ability over and above the 
contributions of pre-existing cognitive ability and educational level. 
 
Fairly similar results were obtained with HbA1C-based diabetes groupings. 
 
 
2. Differences across diabetes medication groups 
 
In principle, cognitive benefit may be achievable with pharmacological interventions targeting 
glycemic control in patients with type 2 diabetes [3]. As a result, medication status of the people 
with diabetes may have influenced the findings. Indeed, if medicines targeting glycemic control had 
raised cognitive ability, then the true older age cognitive ability difference between those with and 
without diabetes would have been larger than the difference that we observed, given that nearly 
half of the people with self-reported diabetes used non-insulin diabetes medication. This would 
have suggested that diabetes may have, after all, impaired general cognitive ability in this sample.  
 
Since we had information on the medications that people used, we could test this. If medications 
targeting glycemic control had improved cognition, we would probably have seen that (a) those on 
non-insulin diabetes medications scored higher than those people with diabetes who did not use 
diabetes medications and (b) the pattern of relative cognitive ability levels at ages 11 and 70 was 
different in those people with diabetes who used non-insulin diabetes medications compared to the 
rest of people with diabetes. Table S1 gives the mean standardized cognitive ability test scores of 
participants on different types of or no diabetes medication. 
 
Contrary to the hypotheses discussed above, Table S1 shows that people on non-insulin diabetes 
drugs had, in fact, lower cognitive ability than those people with diabetes who did not report taking 
any diabetes medications (the number of people on insulin was very low and therefore their mean 
cognitive ability levels are probably not reliable and interpretable). Furthermore, perhaps even 
more important is the finding that the relative cognitive ability test scores (z-scores) were similar in 
age 11 and 70 years in both of these groups (i.e., people on non-insulin diabetes drugs and people 
with diabetes who were not on diabetes medication). That is, although people on diabetes drugs 
tended to have lower cognitive test scores than those people with diabetes who attempted to 
manage their disease without drugs or did not manage it at all, the cognitive ability difference had 
been there already at age 11. As a result, based on these data, it is not likely that using a certain 
type of medicine biased diabetes-related cognitive ability differences in old age relative to the 
differences in childhood. 
 
 
Table S1. Standardized cognitive ability test scores of people on different types of diabetes 
medication or no diabetes medication. 
 
  
Age 11 cognitive ability Age 70 cognitive ability 
 N Mean SD Mean SD 
 Self-reported diabetes 
Diabetes, on insulin 11 -0.44 0.55 -0.06 0.72 
Diabetes, on other 
diabetes drug 41 -0.55 1.22 -0.60 1.21 
Diabetes, no drug 33 0.01 1.04 0.01 1.12 
No diabetes 932 0.03 0.99 0.03 0.98 
 
HbA1C-based diabetes 
Diabetes, on insulin 11 -0.44 0.55 -0.06 0.72 
Diabetes, on other 
diabetes drug 39 -0.58 1.22 -0.65 1.22 
Diabetes, no drug 71 -0.12 0.98 -0.11 1.15 
No diabetes 869 0.04 0.99 0.04 0.97 
 
NOTE: SD = standard deviation. 
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